Parametric Portfolio Associates’s Rubius Therapeutics, Inc RUBY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$289K Buy
52,432
+70
+0.1% +$445 ﹤0.01% 3298
2021
Q4
$507K Sell
52,362
-33,347
-39% -$462K ﹤0.01% 3067
2021
Q3
$1.53M Sell
85,709
-51,470
-38% -$1.12M ﹤0.01% 2586
2021
Q2
$3.35M Buy
137,179
+46,511
+51% +$1.16M ﹤0.01% 2130
2021
Q1
$2.4M Buy
90,668
+42,709
+89% +$624K ﹤0.01% 2666
2020
Q4
$364K Buy
47,959
+8,750
+22% +$52K ﹤0.01% 3522
2020
Q3
$196K Sell
39,209
-7,435
-16% -$39.4K ﹤0.01% 3662
2020
Q2
$279K Buy
46,644
+33,597
+258% +$198K ﹤0.01% 3505
2020
Q1
$58K Sell
13,047
-3,338
-20% -$24.8K ﹤0.01% 3816
2019
Q4
$156K Buy
+16,385
New +$158K ﹤0.01% 3793

Other funds holding RUBY